As various countries contend with a second wave of Covid-19 outbreaks, many emerging markets are pinning their hopes on a vaccine that will allow them to confidently reopen their economies without the fear of limited health services being overwhelmed.
As the Covid-19 pandemic fractures international supply chains and exposes vulnerabilities in the health care systems of emerging markets, Indonesia is looking to strengthen its pharmaceuticals industry through reforms and overseas investments.
As Thailand begins to gradually ease coronavirus-related restrictions, the government is looking to cement the country’s position as an advanced medical hub in Asia.
How are telemedicine platforms easing the burden of Covid-19 on Indonesia’s hospitals and medical professionals?
With cumulative global deaths from Covid-19 exceeding 22,000 from over 480,000 cases as of March 26, Indonesia – the world’s fourth-most populous country and the largest economy in South-east Asia – reported a cumulative total of 893 cases and 78 deaths.
Stay updated on how some of the world’s most promising markets are being affected by the Covid-19 pandemic, and what actions governments and private businesses are taking to mitigate challenges and ensure their long-term growth story continues.
Register now and also receive a complimentary 2-month licence to the OBG Research Terminal.
Register Here×